The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $501,906 in first-year total cost, median $250,953.
Most frequent study sections
- Clinical and Integrative Cardiovascular Sciences Study Section[CICS]1
- Myocardial Ischemia and Metabolism Study Section[MIM]1
Most frequent institutions
- BETH ISRAEL DEACONESS MEDICAL CENTER1
- NORTHEASTERN UNIVERSITY1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2019 | Sex-Specific Differences in the Development of Anthracycline Cardiotoxicity1R21HL148748-01 | ASNANI, AARTI | BETH ISRAEL DEACONESS MEDICAL CENTER, MA | $258,750 | CICS |
| 2019 | Evaluation of aortic stiffening as an early indicator of anthracycline-induced cardiotoxicity1R21HL148747-01 | BELLINI, CHIARA | NORTHEASTERN UNIVERSITY, MA | $243,156 | MIM |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.